Bionote IPO - Delayed Timeline & Updated Valuation Analysis
Our updated base case valuation is target price of 16,966 won per share, which is 6% lower than the low end of the IPO price range.
495 Views
ECM Weekly (13th Nov 2022) - I-Tail, Blibli, Nykaa, PB Fin, Five Star, Archean, GDRs, Axis Bank
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
645 Views
Bionote Pre-IPO - Thoughts on Valuation
Bionote (377740 KS) is looking to raise approximately US$200m in its Korean IPO. The IPO would consist of both a primary and secondary selldown.
403 Views
Archean Chemical Industries IPO - Outstanding Growth but Keep an Eye on Leverage
Archean Chemical Industries (0810406D IN) is looking to raise about US$176m in its India IPO. ACI has been growing in recent years. However, the...
383 Views
ECM Weekly (6th Nov 2022) - Giant Biogene, Blibli, Betagro, Bionote, Fusion, Medanta, Bikaji, Axis
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
504 Views